Effective Input Delivery Assurance¶

Manage what becomes usable at the point of action, not merely what was supplied upstream.

Practical summary: Manage what becomes usable at the point of action, not merely what was supplied upstream.

A system can report generous supply while the intended target receives little usable input. Material can be degraded, delayed, diverted, transformed into an inactive form, blocked at an access boundary, sequestered elsewhere, cleared too early, or delivered when the target cannot use it. This archetype replaces nominal supply as the success metric with a measured supplied-to-reached-to-usable chain.

The pattern is not limited to pharmacology. The “input” can be a medicine, nutrient, reagent, message, budget, service, training resource, or operational capability. The “point of action” can be a receptor, tissue, process stage, decision maker, household, user workflow, or receiving service. The same reasoning applies whenever delivery and effective use are separated by lossy stages.

Problem pattern¶

The structural error is proxy substitution: the upstream quantity is observable and controllable, so it is treated as if it were the effective quantity. That shortcut fails whenever route, form, timing, access, uptake, transformation, or retention matters. A low response then invites more supply, even when the real problem is a lossy path. This can increase waste, congestion, toxicity, inequity, or off-target accumulation without repairing the target deficit.

Typical signs include rising input with weak response, large differences across routes or recipients, high total exposure with low target action, delayed or erratic effects, and repeated claims that something was “delivered” even though intended users or target sites could not use it.

Core intervention¶

Define four things before optimizing anything: what was supplied, where action must occur, what form counts as usable, and within what time window. Then map the stages between supply and action, measure or estimate survival and conversion at diagnostic checkpoints, reconcile losses, and calculate the usable target-site fraction with uncertainty. Repair the dominant loss mechanism before increasing upstream quantity, and verify that greater availability produces the intended response without exceeding off-target limits.

The intervention therefore turns a single vague question—“Why did the input not work?”—into a sequence of testable questions: Was it supplied? Did it survive transit? Did it reach the right boundary? Did it cross? Was it converted or released into an active form? Was it retained long enough? Was the target capable of responding? Where did the remainder go?

Structural model¶

A compact representation is:

A_eff(t) = U_target(t) / S_input(t₀)

where S_input is the supplied quantity at a declared accounting boundary and U_target is the usable-equivalent quantity at the declared action locus within the governed time window. In a staged path, the effective fraction can be decomposed as the product of stage survival ratios and usable-form conversion. That decomposition is diagnostic rather than merely descriptive: a 20% end-to-end fraction can arise from one severe loss or several moderate losses, and those cases require different repairs.

The ratio must not stand alone. Report absolute supplied and usable quantities, latency, duration or persistence, uncertainty, response, and off-target burden. A high fraction of an inadequate supply may still be insufficient; a low fraction of a huge supply may still create dangerous exposure elsewhere.

Intervention sequence¶

Define the managed input, supply boundary, quantity, form, route, timing, and observation window.
Define the action locus and the conditions under which the input counts as usable there.
Map transport, handoff, transformation, access, uptake, storage, sequestration, clearance, and competing-sink stages.
Choose direct measurements or validated proxies at stages that can distinguish dominant loss mechanisms.
Convert heterogeneous forms to usable-equivalent units and reconcile stage quantities with uncertainty.
Estimate effective availability and decompose loss into transport, conversion, access, uptake, timing, and off-target categories.
Select the least burdensome correction: reduce loss, change route or form, improve access or uptake, adjust timing, or alter supply only when necessary.
Monitor target response, adverse effects, accumulation, and distribution across recipients or contexts.
Re-estimate the path after intervention; do not assume a one-time availability ratio remains stable.
Stop escalation or reverse course when off-target burden, uncertainty, or response evidence exceeds the governed boundary.

Key components¶

The required components form an auditable chain rather than a loose checklist. Each component protects a distinct inference that would otherwise be collapsed into “delivered.”

Component	Description
Supplied Input Baseline ↗	Defines the quantity, form, timing, route, source, and accounting boundary of what enters the system. Without a stable denominator, availability ratios can improve merely because supply was redefined or undercounted.
Point-of-Action Definition ↗	Names the physical, organizational, informational, or functional locus where the input must be present and usable to produce the intended effect. The point of action may be a receptor, tissue, machine stage, decision role, user context, or service encounter; a convenient upstream proxy is not automatically sufficient.
Delivery Path and Stage Map ↗	Represents the ordered routes, transformations, barriers, handoffs, stores, and competing sinks between supply and action. The map should distinguish transit, conversion, access, uptake, sequestration, clearance, and off-target destinations when relevant.
Stagewise Availability Measurement ↗	Measures or estimates the amount and form remaining at meaningful checkpoints along the delivery path. This turns one opaque end-to-end loss into diagnosable stage losses and helps separate delivery failure from response insensitivity.
Usable-Form Criterion ↗	Defines what counts as active, accessible, compatible, released, assimilated, or otherwise capable of acting at the target. Total quantity is not enough when material is bound, degraded, untranslated, unauthorized, inaccessible, or in the wrong state.
Effective Availability Ratio ↗	Relates usable quantity at the point of action to the supplied baseline, with uncertainty and time window stated. A common form is A_eff = U_target / S_input. The ratio should be accompanied by absolute quantities, latency, persistence, and confidence.
Loss or Leakage Accounting ↗	Accounts for quantities diverted, degraded, delayed beyond usefulness, consumed, captured, or lost between stages. Reused from Circulation Loop Design. Loss categories must be mutually intelligible and avoid double counting.
Equivalence or Conversion Rule ↗	Converts heterogeneous forms into a common usable-equivalent basis when stages transform the input. Reused from Conservation Accounting. The rule must not assign equal effective weight to forms with different activity or accessibility.
Response Monitoring ↗	Checks whether increased usable availability produces the intended response at the target. Reused from dose and window archetypes. Response validation prevents an availability proxy from becoming the objective after target sensitivity has changed.
Uncertainty Band ↗	States confidence, sampling error, model error, and proxy uncertainty around stage and target-site estimates. Reused across accepted archetypes. Uncertainty should widen when the point of action cannot be observed directly.
Adjustment Rule ↗	Specifies how route, form, timing, carrier, access, activation, or supplied amount changes in response to measured losses. Reused from Therapeutic Window Management and other feedback patterns. The rule should prefer loss reduction over blind upstream escalation.
Off-Target Burden Boundary ↗	Limits accumulation, exposure, cost, or harm outside the intended action locus while availability is improved. This prevents a low target fraction from being compensated by unsafe or wasteful oversupply that raises total burden elsewhere.

Optional companion components¶

Optional components are selected according to consequence, persistence, recipient variation, and the degree to which improving target availability could create excess elsewhere.

Target Range: Defines an acceptable band for usable target-site availability or response. Reused from Dose–Response Calibration; useful when both underavailability and excess are harmful.
Minimum Effective Input: Defines the least supplied or usable input that reliably produces the desired outcome. Reused from Minimum Effective Intervention and Dose–Response Calibration.
Clearance Path: Represents removal of unused, excess, or accumulated input from non-target locations. Reused from Bioaccumulation Prevention; important when efforts to increase availability also increase residual burden.
Accumulation Threshold: Marks a stored burden beyond which delayed harm, congestion, or toxicity becomes unacceptable. Reused from Bioaccumulation Prevention.
Downstream Absorption Capacity: Represents the target or recipient capacity to admit, process, and use incoming input. Reused from Controlled Stress Relief; it helps distinguish supply shortage from uptake limitation.
Audit Trace: Preserves assumptions, measurement methods, conversion factors, adjustments, and observed responses. Reused from accepted governance and invariant archetypes; essential where indirect proxies or safety-sensitive decisions are used.
Sensitivity Profile: Represents differences in response or harm across recipients, contexts, or target states. Reused from Therapeutic Window Management and Robustness Margin Design.
Managed Input or Exposure: Names the intervention, substance, information, resource, or service whose effective availability is controlled. Reused from Therapeutic Window Management.
Side-Effect Signal: Monitors adverse effects or collateral burden while availability is adjusted. Reused from dose and titration archetypes.

Common mechanisms¶

Mechanisms implement measurement or adjustment. None is the archetype by itself; a tracer without an action-locus definition, or a dashboard without an adjustment and safety rule, can produce precise but irrelevant numbers.

Tagged Input Tracing (method): Marks or fingerprints input so its path, transformation, capture, and destination can be measured across stages.
Stagewise Availability Assay (test_or_assessment): Measures total and usable-equivalent quantity at selected delivery stages.
Target-Site Sampling or Proxy Validation (test_or_assessment): Samples the action locus directly or validates an upstream proxy against target-site availability and response.
Availability Funnel Dashboard (metric_or_dashboard): Displays supplied, surviving, reached, usable, and effective quantities with stage losses and uncertainty.
Route–Form–Timing Optimization (method): Compares delivery routes, formulations, carriers, schedules, or access channels to increase usable target-site fraction.
First-Pass Loss Audit (test_or_assessment): Quantifies early degradation, diversion, filtering, or capture before the input enters the effective pathway.
Mass Balance (method): Reconciles supplied, transformed, stored, lost, cleared, and recovered quantities.
Sankey Loss Map (artifact): Visualizes branching flow and stage losses in quantity-proportional form.
Advection–Diffusion or Transport Modeling (method): Estimates delivery, dispersion, delay, and loss through a physical or abstract transport path.
Uptake Confirmation (test_or_assessment): Confirms that a recipient, boundary, or target actually admitted and incorporated what was delivered.
Dosage Window Protocol (protocol): Keeps adjusted exposure within a beneficial rather than ineffective or harmful band.
Medication Dose Calibration (procedure): Calibrates supplied dose against measured response and adverse effects.
Minimum Effective Dose Review (procedure): Tests whether the desired effect can be maintained with lower supplied burden after availability improves.
Exposure–Dose Curve (method): Maps supplied exposure to internal or target-site dose when direct proportionality is unreliable.

Parameter dimensions¶

Supply boundary: planned, dispatched, administered, received, or verified entry into the governed system.
Action locus: one physical site, a distributed functional region, a recipient context, or an organizational decision point.
Usable form: active versus inactive, free versus bound, accessible versus inaccessible, understood versus merely encountered, authorized versus nominally allocated.
Path structure: linear stages, branching networks, competing sinks, storage pools, recirculation loops, or repeated handoffs.
Time: arrival latency, peak, residence time, duration above an effective threshold, cumulative area, and clearance.
Population and context: route, recipient, location, state, co-exposures, capacity, and environmental conditions.
Measurement: direct sampling, validated proxy, model estimate, intermittent sample, or continuous telemetry.
Adjustment lever: route, form, carrier, timing, sequence, access design, activation, uptake support, clearance, or supplied amount.
Burden boundary: toxicity, accumulation, waste, cost, congestion, surveillance, coercion, or inequitable distribution.

Invariants to preserve¶

The point of action and usable-form definition remain explicit and stable unless formally revised.
Mass, value, or information accounting does not double count transformed or diverted input.
Target response is validated independently of the availability proxy.
Off-target burden, harm, and inequitable access remain within declared limits.
Adjustments remain reversible or bounded where uncertainty is high.
Measurement methods and conversion factors remain traceable across time.

These invariants prevent the metric from becoming a Goodhart target. The point is not to maximize an availability ratio at any cost; it is to secure legitimate, safe, usable input at the target with traceable evidence.

Target outcomes¶

Higher usable target-site quantity per unit supplied.
Lower waste, upstream overprovisioning, and off-target accumulation.
Clear attribution of dominant loss stages and recipient differences.
More reliable relation between planned input and realized effect.
Safer dose, resource, or access adjustments.
Earlier detection of route, form, timing, conversion, or uptake drift.
Better comparability across delivery channels and contexts.

Recognized variants¶

Transport-Limited Availability¶

Improve effective availability when the main loss occurs while an input is transported through a path, network, medium, or sequence of barriers. The limiting variable is transport survival and arrival rather than activation or recipient uptake.

Use it when:

A supplied input is usable in principle but little reaches the point of action.
Loss, delay, dispersion, interception, or route impedance dominates conversion.
Alternative routes, carriers, timing, or staging can change the delivered fraction.

It remains under the parent because it uses the same supplied, reached, usable, and response boundaries and seeks a higher effective fraction without unsafe oversupply.

Activation-Limited Availability¶

Improve effective availability when an input reaches the relevant vicinity but remains inactive, incompatible, bound, degraded, or otherwise unusable until transformed. The dominant gap is between reached quantity and usable form, not between supply and arrival.

Use it when:

Physical arrival is adequate but effect remains weak.
A conversion, release, unbinding, translation, or activation step is required.
Inactive and active forms can be distinguished or credibly proxied.

It remains under the parent because the intervention still manages the fraction of supplied input that becomes usable at the action locus.

Access-and-Uptake-Limited Availability¶

Improve effective availability when an input reaches a boundary or recipient environment but is not admitted, absorbed, retained, or integrated where action occurs. Recipient-side access and assimilation, rather than upstream supply, is the binding constraint.

Use it when:

The recipient or target has selective access, uptake, assimilation, or retention limits.
Supply is visible at the boundary but low inside the operative locus.
Capacity building, interface adaptation, timing, or delivery form can change uptake.

It remains under the parent because it preserves the same effective-fraction objective and stagewise loss accounting.

Tradeoffs¶

Direct target-site measurement versus invasiveness, cost, latency, or disruption.
Higher effective fraction versus faster clearance, lower persistence, or lower buffering.
Loss reduction versus route or formulation complexity.
Recipient-specific calibration versus standardization and operational simplicity.
Upstream supply reduction versus resilience to demand spikes and measurement error.
Detailed stage instrumentation versus monitoring burden and perturbation of the path being measured.
Improved target delivery versus off-target exposure, concentration peaks, inequity, or local saturation.
Fast proxy feedback versus slower but more valid outcome evidence.

Failure modes and mitigations¶

Supply proxy substitution¶

Cause: Upstream dispatch, budget, dose, or publication is treated as target availability.
Mitigation: Define the action locus and validate stage or target-site measurements before using supply as a proxy.

Wrong usable-form definition¶

Cause: Total quantity is counted even when inactive, bound, inaccessible, degraded, unauthorized, or mistimed.
Mitigation: Specify the active or usable state and conversion rule; assay total and usable fractions separately.

Unsafe compensatory oversupply¶

Cause: Low availability is corrected only by increasing upstream input.
Mitigation: Repair the dominant loss stage first and enforce therapeutic, accumulation, cost, and off-target boundaries.

Proxy drift¶

Cause: A once-valid upstream or circulating measure stops tracking the action locus.
Mitigation: Periodically revalidate proxies against direct sampling or response and add drift triggers.

Availability–sensitivity confounding¶

Cause: Weak response is attributed to low delivery when target sensitivity, receptor function, or decision context changed.
Mitigation: Measure availability and response separately; test sensitivity before escalating delivery.

Double-counted transformation¶

Cause: Input and transformed forms are summed without a common-equivalent rule.
Mitigation: Use explicit conversion factors and conservation reconciliation.

Ignored timing and persistence¶

Cause: A snapshot ratio misses delayed arrival, short residence, or intermittent action.
Mitigation: Define the governed time window and report peak, duration, latency, and area-under-availability when relevant.

Off-target success¶

Cause: Total internal quantity rises but is sequestered or concentrated outside the intended locus.
Mitigation: Measure destination distribution and enforce an off-target burden boundary.

Average hides subgroup exclusion¶

Cause: A good population mean masks low availability for routes, recipients, locations, or contexts.
Mitigation: Stratify stage and response evidence and design access or form adjustments for affected groups.

Instrumentation perturbs delivery¶

Cause: Tags, sampling, or monitoring alter transport, binding, behavior, or uptake.
Mitigation: Validate measurement noninterference and triangulate with independent methods.

Neighbor distinctions¶

Neighbor	Why this archetype is different

| Dose–Response Calibration | Maps usable input intensity to response. Effective-Input Delivery Assurance explains and controls how supplied input becomes that usable input. |

| Therapeutic Window Management | Keeps exposure within beneficial and harmful bounds. This archetype diagnoses and improves the fraction reaching the action locus, while borrowing window controls as safety guardrails. |

| Conservation Accounting | Tracks quantities across transformations. This archetype adds point-of-action and usable-form definitions, target-site and response validation, adjustment logic, and off-target burden governance. |

| Network Flow Optimization | Optimizes throughput or cost through a network. This archetype cares whether flow reaches the right locus in a usable form and may prefer lower throughput with higher effective fraction. |

| Bottleneck Identification and Relief | Finds the stage limiting whole-system throughput. This archetype can diagnose multiple multiplicative losses and conversion failures even when no single throughput bottleneck dominates. |

| Absorptive Capacity Building | Builds long-run ability to recognize and apply external knowledge. Access-and-uptake availability may reuse recipient-capacity ideas but remains a supplied-to-usable control problem. |

| Bioaccumulation Prevention | Prevents stored burden from exceeding clearance. It is a companion when availability interventions increase persistence or off-target storage. |

| Saturation Avoidance | Prevents a limited receptor or channel from receiving more input than it can use. Low availability can coexist with local saturation elsewhere. |

| Minimum Effective Intervention | Minimizes intervention intensity that produces an effect. Availability assurance can lower the needed supplied intensity by reducing delivery losses. |

| Pipeline Staging | Organizes work or flow into ordered stages. This archetype uses stages diagnostically to relate supply to target-site usable quantity and response. |

Examples¶

Pharmacology: An oral drug has high administered dose but low unbound target-tissue concentration; tracing identifies first-pass metabolism and protein binding, leading to a formulation change rather than simple dose escalation.
Humanitarian Aid: A program tracks aid budget, procurement, dispatch, local arrival, household access, and actual usable receipt, then redesigns identity and pickup requirements at the largest loss stage.
Workforce Training: An organization measures content issued, accessed, understood, retained, and applied in real tasks, then changes scheduling and practice support where uptake fails.
Industrial Chemistry: A plant distinguishes reagent fed from active reagent at the reaction zone and reduces degradation by changing carrier, mixing order, and residence time.
Communications: A service measures emitted, delivered, decoded, admitted, and actioned messages, revealing that receiver queue policy rather than transmission loss limits effective delivery.

Extended example¶

A public health program distributes an oral treatment and reports strong coverage because the number of doses issued matches the target population. Clinical response remains uneven and adverse effects rise in one subgroup. The program defines the point of action and usable form, maps administration, dissolution, absorption, first-pass metabolism, circulation, tissue access, binding, and clearance, and combines targeted sampling with response and side-effect evidence. It finds that one formulation degrades before absorption for many recipients, while another subgroup reaches high systemic levels but low free target-site levels. Rather than raising the dose universally, the program changes formulation and timing for the first group, adds interaction screening for the second, lowers supplied dose where improved availability raises exposure, and periodically revalidates the circulating proxy against target response. The result is more reliable effect with lower total administered burden and fewer adverse events.

Non-examples¶

Counting shipped units as successful delivery without checking access or use.
Selecting the best response among already measured target-site doses.
Drawing a Sankey diagram without defining usable form or adjustment policy.
Increasing dose until response appears while ignoring toxicity and off-target accumulation.
Building general learning capability with no bounded supplied-to-usable input chain.

Implementation checklist¶

Editorial note¶

The term “bioavailability” is retained as the motivating accepted prime and a domain alias, while the canonical draft name is intentionally cross-domain. Human review should test whether that abstraction transfers cleanly without encouraging biological metaphors where institutional access, rights, or power are the true causes of low usable delivery.

Common Mechanisms¶

Advection-Diffusion or Transport Modeling — Predicts how much of an input reaches the target — and how much washes out or piles up along the way — by modeling its advective and diffusive transport through the delivery path.
Availability Funnel Dashboard — Shows supply narrowing stage by stage into the fraction actually usable at the point of action, and tracks the response and off-target signals it produces over time.
Dosage Window Protocol — Sets a standing acceptable range for a managed input — a floor for effect and a ceiling for harm — with codified rules for correcting back into it.
Exposure Dose Curve — Maps how response changes across the full range of an input — from no effect, through the useful zone, to diminishing returns and harm — so any single level can be read off the curve.
First-Pass Loss Audit — Isolates and books the loss at the first boundary the input must cross — the earliest, largest, most easily hidden drop, before any downstream stage can even see it.
Mass Balance — Applies conservation bookkeeping across a declared boundary so a hazard that 'disappears' from one channel must reappear as an outflow somewhere — and the unaccounted gap localises the leak.
Medication Dose Calibration — Dials an individual's dose to their own observed response and adverse signals, titrating under professional oversight until the effect lands in target without tipping into harm.
Minimum Effective Dose Review — Periodically re-examines a standing input to find the lowest level that still works, deliberately shedding dose to reduce off-target burden without losing the effect.
Route–Form–Timing Optimization — Raises the fraction that arrives usable by changing how the input is delivered — its route, its form, and its timing — instead of increasing the amount supplied.
Sankey Loss Map — A flow diagram whose branch widths are drawn to scale, exposing where a supplied input is lost stage by stage and what fraction survives to do useful work.
Stagewise Availability Assay — Measures how much of the input remains in usable form at each stage of the path, turning one supplied figure into a stagewise availability profile with error bars.
Tagged Input Tracing — Attaches a distinguishable tag to a batch of the input and follows that same material through the system, mapping where it actually goes — and where it leaks or is diverted.
Target-Site Sampling or Proxy Validation — Measures what is actually present at the point of action — by sampling the target directly, or by validating an accessible proxy that provably tracks it.
Uptake Confirmation — Verifies that a supplied input actually arrived and was taken up in usable form at the point of action, rather than trusting that dispatch equals receipt.

Compression statement¶

Define the supplied baseline, point of action, and usable form; map the delivery and transformation path; measure stagewise survival and target-site availability; calculate the effective fraction with uncertainty; identify transport, conversion, access, uptake, sequestration, and clearance losses; adjust route, form, timing, access, activation, or supply; and verify response without exceeding off-target burden.

Canonical formula: Effective availability A_eff(t) = U_target(t) / S_input(t0), where U_target is usable-equivalent quantity at the defined action locus within the governed time window and S_input is supplied quantity at the accounting boundary. Diagnose A_eff = Π_i r_i × c_use, with stage survival ratios r_i and usable-form conversion c_use; report absolute quantities, delay, persistence, uncertainty, and off-target burden alongside the ratio.

Abstractions this archetype builds on — directly (a source ingredient) or as a related pattern. Links follow the typed catalog namespace.

Built directly on (5)

Bioavailability: The fraction of what is supplied that arrives, in usable form, at the locus where it acts.
Flow: Structured movement of energy, matter, or information.
Measurement: Mapping a target's attribute onto a scale via an instrument and procedure, yielding a value-plus-uncertainty tied to a unit and frame.
Resource Management: Allocation of finite assets.
Transformation: A rule-governed mapping that restructures an input into a different output, holding certain invariants fixed while altering others.

Also references 25 related abstractions

Absorptive Capacity: Ability to integrate knowledge.
Bioaccumulation: Progressive concentration.
Boundary: Defines system limits.
Clearance Rate: The rate at which a bounded system removes substrate is a control surface separable from input, with kinetic regime and vulnerability that input-side reasoning misses.
Conservation Laws: Quantities remain constant.
Constraint: Limits possibilities to guide outcomes.
Damping: Reduce oscillations.
Diffusion: Spread over time.
Dose-Response Relationship: Input-output mapping.
Feedback: Outputs influence inputs.

▸ Show 15 more

Variants¶

Narrower or domain-specific specializations that share this archetype's core structure. Recognized variants are established; candidate variants are provisional.

Transport-Limited Availability · subtype · recognized

Improve effective availability when the main loss occurs while an input is transported through a path, network, medium, or sequence of barriers.

Distinct from parent: The parent governs the entire supplied-to-usable chain; this subtype concentrates measurement and intervention on transit losses and route choice.
Use when: A supplied input is usable in principle but little reaches the point of action; Loss, delay, dispersion, interception, or route impedance dominates conversion; Alternative routes, carriers, timing, or staging can change the delivered fraction.
Typical domains: pharmacology, supply and service delivery, communications and distributed systems
Common mechanisms: tagged input tracing, advection diffusion or transport modeling, sankey loss map, route form timing optimization

Activation-Limited Availability · subtype · recognized

Improve effective availability when an input reaches the relevant vicinity but remains inactive, incompatible, bound, degraded, or otherwise unusable until transformed.

Distinct from parent: The parent spans transport, access, and activation; this subtype centers the conversion rule and usable-form assay.
Use when: Physical arrival is adequate but effect remains weak; A conversion, release, unbinding, translation, or activation step is required; Inactive and active forms can be distinguished or credibly proxied.
Typical domains: pharmacology and toxicology, knowledge translation, industrial process control
Common mechanisms: stagewise availability assay, target site sampling or proxy validation, first pass loss audit, route form timing optimization

Access-and-Uptake-Limited Availability · domain variant · recognized

Improve effective availability when an input reaches a boundary or recipient environment but is not admitted, absorbed, retained, or integrated where action occurs.

Distinct from parent: The parent is domain-general across all stages; this variant adds boundary permeability, recipient capacity, and uptake confirmation.
Use when: The recipient or target has selective access, uptake, assimilation, or retention limits; Supply is visible at the boundary but low inside the operative locus; Capacity building, interface adaptation, timing, or delivery form can change uptake.
Typical domains: drug delivery, training and knowledge transfer, public benefits and service access
Common mechanisms: uptake confirmation, target site sampling or proxy validation, availability funnel dashboard, route form timing optimization

Near names: Bioavailability Management, Usable-Fraction Delivery Assurance, Delivered-to-Effective Conversion Control, Effective Input Availability, Last-Mile Effectiveness Assurance.

Effective Input Delivery Assurance¶

Problem pattern¶

Core intervention¶

Structural model¶

Intervention sequence¶

Key components¶

Optional companion components¶

Common mechanisms¶

Parameter dimensions¶

Invariants to preserve¶

Target outcomes¶

Recognized variants¶

Transport-Limited Availability¶

Activation-Limited Availability¶

Access-and-Uptake-Limited Availability¶

Tradeoffs¶

Failure modes and mitigations¶

Supply proxy substitution¶

Wrong usable-form definition¶

Unsafe compensatory oversupply¶

Proxy drift¶

Availability–sensitivity confounding¶

Double-counted transformation¶

Ignored timing and persistence¶

Off-target success¶

Average hides subgroup exclusion¶

Instrumentation perturbs delivery¶

Neighbor distinctions¶

Examples¶

Extended example¶

Non-examples¶

Implementation checklist¶

Editorial note¶

Common Mechanisms¶

Compression statement¶

Related Abstractions¶

Variants¶